MAPT and Mental deterioration: To do so, we performed moderated mediation analyses to test the mediating effect of tau on the associations between each synaptic biomarker (i.e., complexin-I and SNARE protein-protein interactions) and cognitive decline at two ages of menopause: age 45 (i.e., earlier) and age 50 (i.e., average).